Likarda

Likarda is a biotechnology Contract Development and Manufacturing Organization (CDMO) that develops enabling technologies to transform the delivery of cell therapies, with the goal of providing sustainable reversal for patients with chronic or fatal diseases. Our revolutionary method of encapsulating cells in inert hydrogels, known as Core-Shell Spherification® (CSS), protects cells from damage, keeps them viable, and ensures they remain at the target location within the body.